These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. The receptor for advanced glycation end products impairs host defense in pneumococcal pneumonia. van Zoelen MA; Schouten M; de Vos AF; Florquin S; Meijers JC; Nawroth PP; Bierhaus A; van der Poll T J Immunol; 2009 Apr; 182(7):4349-56. PubMed ID: 19299735 [TBL] [Abstract][Full Text] [Related]
11. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice. Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043 [TBL] [Abstract][Full Text] [Related]
12. Polyamine transporter in Streptococcus pneumoniae is essential for evading early innate immune responses in pneumococcal pneumonia. Rai AN; Thornton JA; Stokes J; Sunesara I; Swiatlo E; Nanduri B Sci Rep; 2016 Jun; 6():26964. PubMed ID: 27247105 [TBL] [Abstract][Full Text] [Related]
13. Streptococcus pneumoniae-Induced Oxidative Stress in Lung Epithelial Cells Depends on Pneumococcal Autolysis and Is Reversible by Resveratrol. Zahlten J; Kim YJ; Doehn JM; Pribyl T; Hocke AC; García P; Hammerschmidt S; Suttorp N; Hippenstiel S; Hübner RH J Infect Dis; 2015 Jun; 211(11):1822-30. PubMed ID: 25512625 [TBL] [Abstract][Full Text] [Related]
15. Streptococcus pneumoniae induces expression of the antibacterial CXC chemokine MIG/CXCL9 via MyD88-dependent signaling in a murine model of airway infection. Eliasson M; Mörgelin M; Farber JM; Egesten A; Albiger B Microbes Infect; 2010 Jul; 12(7):565-73. PubMed ID: 20381636 [TBL] [Abstract][Full Text] [Related]
16. Monocyte chemoattractant protein 1 does not contribute to protective immunity against pneumococcal pneumonia. Dessing MC; de Vos AF; Florquin S; van der Poll T Infect Immun; 2006 Dec; 74(12):7021-3. PubMed ID: 16982835 [TBL] [Abstract][Full Text] [Related]
17. Capsules of virulent pneumococcal serotypes enhance formation of neutrophil extracellular traps during in vivo pathogenesis of pneumonia. Moorthy AN; Rai P; Jiao H; Wang S; Tan KB; Qin L; Watanabe H; Zhang Y; Teluguakula N; Chow VT Oncotarget; 2016 Apr; 7(15):19327-40. PubMed ID: 27034012 [TBL] [Abstract][Full Text] [Related]
18. Controlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice. Lima FA; Ferreira DM; Moreno AT; Ferreira PC; Palma GM; Ferreira JM; Raw I; Miyaji EN; Ho PL; Oliveira ML Clin Vaccine Immunol; 2012 Sep; 19(9):1382-92. PubMed ID: 22761301 [TBL] [Abstract][Full Text] [Related]
19. Induction of pro- and anti-inflammatory molecules in a mouse model of pneumococcal pneumonia after influenza. Smith MW; Schmidt JE; Rehg JE; Orihuela CJ; McCullers JA Comp Med; 2007 Feb; 57(1):82-9. PubMed ID: 17348295 [TBL] [Abstract][Full Text] [Related]
20. Reduced inflammation and cytokine production in NKLAM deficient mice during Streptococcus pneumoniae infection. Lawrence DW; Kornbluth J PLoS One; 2018; 13(3):e0194202. PubMed ID: 29518136 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]